A recent study was conducted by Neil Sachandani, BS and associates of the Washington University School of Medicine in St. Louis. It was to assess the effectiveness of budesonide for the treatment of chronic rhinosinusitis. Furthermore, they also determined the effects of the steroid in the adrenal function. Suppression of the adrenal glands could lead to absorption of the drug throughout the whole body, which is a known complication.

Budesonide is a corticosteroid used for the treatment of asthma, nasal polyps, hay fever, and sinusitis. It is also used additionally for the treatment of Crohn’s disease.

Researchers prepared a solution containing 0.25 mg budesonide and 5 ml saline. The participants were then instructed to apply the solution in each nostril for 30 days. The participants were also made to fill up questionnaires regarding the symptoms of their condition as well as the related quality of life. This was done twice during the whole period of the study, before administering the treatment and at the end of the treatment period.

All participants reported some forms of improvement in their condition after budesonide therapy. Furthermore, adrenal functions among participants were noted to remain normal. Sixty-seven percent of the respondents even said that they would recommend this method of treatment to their family and friends.

From Eurekalert:

A nasal wash containing the corticosteroid budesonide appears to reduce symptoms of chronic rhinosinusitis without suppressing the function of the adrenal glands, a known complication of this type of drug that would indicate absorption throughout the whole body, according to a report in the March issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.

Budesonide, a steroid nasal wash, can help in minimizing the symptoms of chronic sinusitis without affecting adrenal gland functions, as per a small US Study.

Chronic Sinusitis refers to a continuing inflammation of the nose and sinuses behind it that affects up to 14 percent population of the United States.

Researchers from the Washington University School of Medicine in St. Louis remarked that the study was the first one to scrutinize safety of such a nasal wash. The study also noted that suppression of the functions of the adrenal gland is a known barrier of Budesonide.

From Bio-Medicine.Org:

All participants reported at least some improvement in their sinusitis symptoms, and their adrenal gland function was not affected, the study found. The results were published in the March issue of Otolaryngology – Head & Neck Surgery.

“The clinical significance of this study is that budesonide nasal respules appear safe for short-term use for the relief of symptoms associated with chronic sinusitis,” the researchers concluded. “Budesonide respules seem to provide an effective treatment option for the patient with chronic rhinosinusitis with minimal fear of systemic adverse effects.”

The FDA has yet to give nod to this drug as a nasal wash and this means that nasal wash of this study would be an off-label use of Budesonide.

In the meanwhile, researchers advised the medical fraternity to advise patients about the possible risks associated with long-term usage of Budesonide such as decreased bone mineral density.

As per a recently concluded study, it was revealed that children being administered with inhaled corticosteroids such as budesonide in the past have not been able to show those improvements after stopping the steroid treatment. These results were observed after the Childhood Asthma Management Program (CAMP) clinical trial announced its findings on more than 1,000 children in the age group of 5-12 years.

During the study, it was found that children (now in their late teens) who have been advised steroid therapy in the past and stopped now showed no differences in management of asthma when they were compared with children who received the placebo.

Robert C. Strunk, M.D., a Washington University pediatrician at St. Louis Children’s Hospital and lead author of the study, said that it was quite interesting to note that children tend to do better with the passe of age when it comes to combating asthma.

Inhaled corticosteroids such as budesonide have been regarded as one of the most effective forms of anti-inflammatory treatments for controlling asthma via improving pulmonary function.

From Sciencedaily.com:

“While the kids did get better with age and didn’t seem to need the medicine as much, laboratory measurements indicated that they were still having symptoms, and therefore were primed to an attack if they got a bad cold or were exposed to a significant weather change,” Strunk said.

The researchers determined that continued benefit of these medications likely requires continued use.

“The conclusion is that some kids get better, but the doctor, family and the patient have to pay attention to the symptoms,” Strunk said. “Some of the kids are going to need medicine, and they have to be honest about that possibility.”

In another part of the follow-up study, researchers looked at long-term side effects of the steroid medications on growth, bone density and fracture rate. The only side effect of budesonide was a 0.4-inch decrease in height among female patients compared to the patients who took a placebo during the trial. However, one-fourth of the girls and more than half of the boys in the trial had not reached final adult height at the end of the post-trial period, researchers said. There were no effects of the nedocromil treatment on growth.

Funding from the National Heart, Lung, and Blood Institute and the National Center for Research Resources supported this research.

The study also suggested that if an asthma patient gets cured after being administered with steroid treatment then he should not stop the treatment presuming that asthma is completely cured. It was found that continued benefits of steroid medications require continued usage.